BE

Burr, Egan, Deleage & Co

North America, Massachusetts, United States, Boston

Description

Burr, Egan, Deleage & Co is a venture capital firm investing in IT, healthcare and biotech companies.

Investor Profile

Burr, Egan, Deleage & Co has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 1 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Undisclosed rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Biopharma, Biotechnology, Pharmaceutical.

Stage Focus

  • Undisclosed (100%)

Country Focus

  • United States (100%)

Industry Focus

  • Biopharma
  • Biotechnology
  • Pharmaceutical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Burr, Egan, Deleage & Co frequently co-invest with?

HBM Healthcare Investments
Europe, Zug, Switzerland, Zug
Co-Investments: 1
Audax Group
North America, Massachusetts, United States, Boston
Co-Investments: 1
Polaris Partners
North America, Massachusetts, United States, Boston
Co-Investments: 1
TF
North America, California, United States, El Dorado Hills
Co-Investments: 1
Thomas Weisel Partners
North America, California, United States, San Francisco
Co-Investments: 1
BV
North America, Massachusetts, United States, Boston
Co-Investments: 1

What are some of recent deals done by Burr, Egan, Deleage & Co?

Acusphere

Lexington, Massachusetts, United States

Acusphere is a speciality pharmaceutical company developing cardiovascular drugs for the detection of coronary artery disease.

BiopharmaBiotechnologyPharmaceutical
UndisclosedApr 21, 2003
Amount Raised: $19,000,000